Abstract:AbstractSirtuin 2 (SIRT2) is a member of the sirtuin family of NAD+‐dependent protein deacetylases. In recent years, SIRT2 inhibition has emerged as a promising treatment for neurodegenerative diseases. However, to date, there is no evidence of a specific role for SIRT2 in traumatic brain injury (TBI). We investigated the effects of SIRT2 inhibition on experimental TBI using the controlled cortical impact (CCI) injury model. Adult male mice underwent CCI or sham surgery. A selective brain‐permeable SIRT2 inhibitor, AK‐7, was administrated 30 min before injury. The volume of the brain edema lesion and the water content of the brain were significantly increased in mice treated with AK‐7 (20 mg/kg), compared with the vehicle group, following TBI (p < 0.05 at 1 day and p < 0.05 at 3 days, respectively). Concomitantly, AK‐7 administration greatly worsened neurobehavioral deficits on days 3 and 7 after CCI. Furthermore, blood–brain barrier disruption and matrix metalloproteinases (MMP)‐9 activity increased following SIRT2 inhibition. AK‐7 treatment increased TBI‐induced microglial activation both in vivo and in vitro, accompanied by a large increase in the expression and release of inflammatory cytokines. Mechanistically, SIRT2 inhibition increased both K310 acetylation and nuclear translocation of NF‐κB p65, leading to enhanced NF‐κB activation and up‐regulation of its target genes, including aquaporin 4 (AQP4), MMP‐9, and pro‐inflammatory cytokines. Together, these data demonstrate that SIRT2 inhibition exacerbates TBI by increasing NF‐κB p65 acetylation and activation. Our findings provide additional evidence of an anti‐inflammatory effect of SIRT2.image SIRT2 is a member of the sirtuin family of NAD+‐dependent protein deacetylases. Our study suggests that the SIRT2 inhibitor AK‐7 exacerbates traumatic brain injury (TBI) via a potential mechanism involving increased acetylation and nuclear translocation of NF‐κB p65, resulting in up‐regulation of NF‐κB target genes, including aquaporin 4 (AQP4), matrix metalloproteinase 9 (MMP‐9), and pro‐inflammatory cytokines. Our findings provide additional evidence of an anti‐inflammatory effect of SIRT2.

SIRT2 Inhibitors Can Induce Significant Increases in the Gene Expression of Pro‐inflammatory Factors in Primary Astrocyte Cultures

SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice

SIRT2 is Required for Lipopolysaccharide-Induced Activation of BV2 Microglia.

Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?

AGK2 Alleviates Lipopolysaccharide Induced Neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1

SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease

SIRT1 inactivation switches reactive astrocytes to an antiinflammatory phenotype in CNS autoimmunity.

SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation.

<scp>SIRT</scp>2 inhibition exacerbates neuroinflammation and blood–brain barrier disruption in experimental traumatic brain injury by enhancing <scp>NF</scp>‐κB p65 acetylation and activation

SIRT2 Plays Complex Roles in Neuroinflammation Neuroimmunology-Associated Disorders

Oxidative Stress Induces Increases in the Gene Expression and Protein Levels of SIRT2 in Primary Murine Astrocyte Cultures and PC12 Cells

Sestrin2 remedies neuroinflammatory response by inhibiting A1 astrocyte conversion via autophagy

Effects of Sirtuin 1 on Microglia in Spinal Cord Injury

SIRT1 activation by 2,3,5,6-tetramethylpyrazine alleviates neuroinflammation via inhibiting M1 microglia polarization

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases

SIN‐1 cause downregulation of sirtuin expression in mouse astrocytes

SIRT2 Plays a Key Role in Both Cell Cycle Regulation and Cell Survival of BV2 Microglia.

Sirtuin 1 Alleviates Microglia-Induced Inflammation by Modulating the PGC-1α/Nrf2 Pathway after Traumatic Brain Injury in Male Rats

SIRT2 regulates high mobility group protein B1 nucleoplasmic shuttle and degradation via deacetylation in microglia

Sirt1 regulates microglial activation and inflammation following oxygen-glucose deprivation/reoxygenation injury by targeting the Shh/Gli-1 signaling pathway

SIRT1 Promotes M2 Microglia Polarization via Reducing ROS-Mediated NLRP3 Inflammasome Signaling After Subarachnoid Hemorrhage